Trial Profile
An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2014
Price :
$35
*
At a glance
- Drugs AS 101 (Primary)
- Indications Acquired immunodeficiency syndrome
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Pfizer
- 09 Apr 2014 New trial record